{"id":1841,"date":"2022-02-07T20:01:56","date_gmt":"2022-02-07T19:01:56","guid":{"rendered":"https:\/\/glycanostics.com\/?p=1841"},"modified":"2022-07-08T08:37:25","modified_gmt":"2022-07-08T06:37:25","slug":"validacia-fpsa-glykoprofilu-ako-biomarkera-rakoviny-prostaty-ako-sposob-vyhybania-sa-zbytocnym-biopsiam-a-opakovanym-biopsiam","status":"publish","type":"post","link":"https:\/\/glycanostics.com\/sk\/validacia-fpsa-glykoprofilu-ako-biomarkera-rakoviny-prostaty-ako-sposob-vyhybania-sa-zbytocnym-biopsiam-a-opakovanym-biopsiam\/","title":{"rendered":"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[25],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf\" \/>\n<meta property=\"og:site_name\" content=\"Glycanostics\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-07T19:01:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-08T06:37:25+00:00\" \/>\n<meta name=\"author\" content=\"cagan@seesame.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"cagan@seesame.com\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf\",\"url\":\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf\",\"name\":\"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics\",\"isPartOf\":{\"@id\":\"https:\/\/glycanostics.com\/#website\"},\"datePublished\":\"2022-02-07T19:01:56+00:00\",\"dateModified\":\"2022-07-08T06:37:25+00:00\",\"author\":{\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d\"},\"breadcrumb\":{\"@id\":\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glycanostics.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glycanostics.com\/#website\",\"url\":\"https:\/\/glycanostics.com\/\",\"name\":\"Glycanostics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glycanostics.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d\",\"name\":\"cagan@seesame.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g\",\"caption\":\"cagan@seesame.com\"},\"url\":\"https:\/\/glycanostics.com\/sk\/author\/caganseesame-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf","og_locale":"sk_SK","og_type":"article","og_title":"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics","og_url":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf","og_site_name":"Glycanostics","article_published_time":"2022-02-07T19:01:56+00:00","article_modified_time":"2022-07-08T06:37:25+00:00","author":"cagan@seesame.com","twitter_card":"summary_large_image","twitter_misc":{"Autor":"cagan@seesame.com"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf","url":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf","name":"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m - Glycanostics","isPartOf":{"@id":"https:\/\/glycanostics.com\/#website"},"datePublished":"2022-02-07T19:01:56+00:00","dateModified":"2022-07-08T06:37:25+00:00","author":{"@id":"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d"},"breadcrumb":{"@id":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/glycanostics.com\/wp-content\/uploads\/2022\/02\/OPEN-ACCESS-cancers.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycanostics.com\/"},{"@type":"ListItem","position":2,"name":"Valid\u00e1cia fPSA glykoprofilu ako biomarkera rakoviny prostaty ako sp\u00f4sob vyh\u00fdbania sa zbyto\u010dn\u00fdm biopsi\u00e1m a opakovan\u00fdm biopsi\u00e1m"}]},{"@type":"WebSite","@id":"https:\/\/glycanostics.com\/#website","url":"https:\/\/glycanostics.com\/","name":"Glycanostics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycanostics.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d","name":"cagan@seesame.com","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g","caption":"cagan@seesame.com"},"url":"https:\/\/glycanostics.com\/sk\/author\/caganseesame-com\/"}]}},"_links":{"self":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1841"}],"collection":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/comments?post=1841"}],"version-history":[{"count":1,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1841\/revisions"}],"predecessor-version":[{"id":1842,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1841\/revisions\/1842"}],"wp:attachment":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media?parent=1841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/categories?post=1841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/tags?post=1841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}